A Comparison of Common Mass Spectrometry Approaches for Paleoproteomics | Journal of Proteome Research
![Evolution of the diagnostic value of “the sugar of the blood”: hitting the sweet spot to identify alterations in glucose dynamics | Physiological Reviews Evolution of the diagnostic value of “the sugar of the blood”: hitting the sweet spot to identify alterations in glucose dynamics | Physiological Reviews](https://journals.physiology.org/cms/10.1152/physrev.00015.2022/asset/images/medium/prv-00015-2022r01.png)
Evolution of the diagnostic value of “the sugar of the blood”: hitting the sweet spot to identify alterations in glucose dynamics | Physiological Reviews
![Frontiers | Braincase With Natural Endocast of a Juvenile Rhinocerotinae From the Late Middle Pleistocene Site of Melpignano (Apulia, Southern Italy) Frontiers | Braincase With Natural Endocast of a Juvenile Rhinocerotinae From the Late Middle Pleistocene Site of Melpignano (Apulia, Southern Italy)](https://www.frontiersin.org/files/Articles/519029/feart-08-00094-HTML/image_m/feart-08-00094-g007.jpg)
Frontiers | Braincase With Natural Endocast of a Juvenile Rhinocerotinae From the Late Middle Pleistocene Site of Melpignano (Apulia, Southern Italy)
![hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia - ScienceDirect hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379122002609-fx1.jpg)
hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia - ScienceDirect
![Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/sites/books/NBK279141/bin/pharmaco-agent-diab2-Image007.jpg)
Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf
![HEM-B, TDT, and SCD - Expert Analysis - Nonmalignant Heme - 2020 ASH Annual Meeting - Oncology - Clinical Care Options HEM-B, TDT, and SCD - Expert Analysis - Nonmalignant Heme - 2020 ASH Annual Meeting - Oncology - Clinical Care Options](https://www.clinicaloptions.com/-/media/oncology/conferences/hematology-2020/nonmalignant-heme/ash_2020_nonmalignant_thumb-32.png?rev=fbf267befb564e30b8a862ed77b830bf)
HEM-B, TDT, and SCD - Expert Analysis - Nonmalignant Heme - 2020 ASH Annual Meeting - Oncology - Clinical Care Options
![HEM-B, TDT, and SCD - Expert Analysis - Nonmalignant Heme - 2020 ASH Annual Meeting - Oncology - Clinical Care Options HEM-B, TDT, and SCD - Expert Analysis - Nonmalignant Heme - 2020 ASH Annual Meeting - Oncology - Clinical Care Options](https://www.clinicaloptions.com/-/media/oncology/conferences/hematology-2020/nonmalignant-heme/ash_2020_nonmalignant_thumb-33.png?rev=c20c8789f8f846f38ca53fdb666fdc6b)
HEM-B, TDT, and SCD - Expert Analysis - Nonmalignant Heme - 2020 ASH Annual Meeting - Oncology - Clinical Care Options
![HEM-B, TDT, and SCD - Expert Analysis - Nonmalignant Heme - 2020 ASH Annual Meeting - Oncology - Clinical Care Options HEM-B, TDT, and SCD - Expert Analysis - Nonmalignant Heme - 2020 ASH Annual Meeting - Oncology - Clinical Care Options](https://www.clinicaloptions.com/-/media/oncology/conferences/hematology-2020/nonmalignant-heme/ash_2020_nonmalignant_thumb-30.png?rev=2a0d015e656f42d884f08fb7a85888c0)
HEM-B, TDT, and SCD - Expert Analysis - Nonmalignant Heme - 2020 ASH Annual Meeting - Oncology - Clinical Care Options
Comparative Efficacy and Safety of Deferoxamine, Deferiprone and Deferasirox on Severe Thalassemia: A Meta-Analysis of 16 Randomized Controlled Trials | PLOS ONE
![IGF‑IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway IGF‑IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway](https://www.spandidos-publications.com/article_images/or/44/3/OR-44-03-1094-g04.jpg)
IGF‑IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway
Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT-4 and HCT 116 Cells
![Frontiers | Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells Frontiers | Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells](https://www.frontiersin.org/files/Articles/728172/fcell-09-728172-HTML/image_m/fcell-09-728172-g001.jpg)